10x Genomics, Inc. (TXG) DCF Valuation

10x Genomics, Inc. (TXG) DCF Valuation
  • ✓ Totalmente Editável: Adapte-Se Às Suas Necessidades No Excel Ou Planilhas
  • ✓ Design Profissional: Modelos Confiáveis ​​E Padrão Da Indústria
  • ✓ Pré-Construídos Para Uso Rápido E Eficiente
  • ✓ Não É Necessária Experiência; Fácil De Seguir

10x Genomics, Inc. (TXG) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Evaluate 10x Genomics, Inc.'s financial outlook like an expert! This (TXG) DCF Calculator provides pre-filled financial data and offers full flexibility to modify revenue growth, WACC, margins, and other essential assumptions to align with your projections.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue 245.9 298.8 490.5 516.4 618.7 790.1 1,008.8 1,288.2 1,644.9 2,100.3
Revenue Growth, % 0 21.53 64.13 5.28 19.81 27.69 27.69 27.69 27.69 27.69
EBITDA -20.9 -513.8 -24.6 -128.5 -205.1 -271.1 -346.1 -441.9 -564.3 -720.6
EBITDA, % -8.49 -171.92 -5.01 -24.88 -33.15 -34.31 -34.31 -34.31 -34.31 -34.31
Depreciation 7.1 19.0 28.3 33.0 43.6 44.9 57.4 73.3 93.6 119.5
Depreciation, % 2.87 6.36 5.76 6.39 7.05 5.69 5.69 5.69 5.69 5.69
EBIT -28.0 -532.8 -52.8 -161.5 -248.7 -305.9 -390.6 -498.8 -636.9 -813.3
EBIT, % -11.37 -178.28 -10.77 -31.27 -40.2 -38.72 -38.72 -38.72 -38.72 -38.72
Total Cash 424.2 663.6 587.4 430.0 388.7 704.9 900.0 1,149.3 1,467.5 1,873.9
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables 33.4 51.2 85.3 104.2 114.8
Account Receivables, % 13.57 17.14 17.38 20.18 18.56
Inventories 15.3 30.0 60.0 81.6 73.7 88.8 113.4 144.7 184.8 236.0
Inventories, % 6.21 10.02 12.23 15.81 11.91 11.24 11.24 11.24 11.24 11.24
Accounts Payable 13.0 4.7 17.4 21.6 15.7 27.1 34.6 44.2 56.4 72.0
Accounts Payable, % 5.3 1.58 3.54 4.18 2.54 3.43 3.43 3.43 3.43 3.43
Capital Expenditure -42.8 -38.4 -101.3 -131.7 -49.5 -133.3 -170.3 -217.4 -277.6 -354.5
Capital Expenditure, % -17.39 -12.85 -20.65 -25.5 -8 -16.88 -16.88 -16.88 -16.88 -16.88
Tax Rate, % -2.55 -2.55 -2.55 -2.55 -2.55 -2.55 -2.55 -2.55 -2.55 -2.55
EBITAT -28.2 -541.0 -57.3 -165.5 -255.1 -305.9 -390.6 -498.8 -636.9 -813.3
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -99.5 -601.2 -181.7 -300.5 -269.5 -420.4 -558.6 -713.3 -910.8 -1,163.0
WACC, % 12.82 12.82 12.82 12.82 12.82 12.82 12.82 12.82 12.82 12.82
PV UFCF
SUM PV UFCF -2,506.4
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) -1,186
Terminal Value -10,960
Present Terminal Value -5,995
Enterprise Value -8,502
Net Debt -264
Equity Value -8,238
Diluted Shares Outstanding, MM 117
Equity Value Per Share -70.31

What You Will Get

  • Real 10x Genomics Data: Preloaded financials – from revenue to EBIT – based on actual and projected figures for 10x Genomics, Inc. (TXG).
  • Full Customization: Adjust all critical parameters (yellow cells) like WACC, growth %, and tax rates to fit your analysis needs.
  • Instant Valuation Updates: Automatic recalculations to assess the impact of changes on 10x Genomics’ fair value.
  • Versatile Excel Template: Designed for quick edits, scenario testing, and detailed projections specific to 10x Genomics, Inc. (TXG).
  • Time-Saving and Accurate: Avoid building models from scratch while ensuring precision and flexibility in your evaluations.

Key Features

  • Comprehensive Data: 10x Genomics’ historical financial statements and pre-filled projections.
  • Customizable Parameters: Adjust WACC, tax rates, revenue growth, and EBITDA margins as needed.
  • Real-Time Insights: View 10x Genomics’ intrinsic value update instantly.
  • Visual Data Representation: Interactive dashboard charts showcase valuation results and essential metrics.
  • Designed for Precision: A specialized tool for analysts, investors, and finance professionals.

How It Works

  • Download: Get the pre-configured Excel file containing 10x Genomics, Inc.'s (TXG) financial information.
  • Customize: Modify projections, such as revenue growth, EBITDA %, and WACC.
  • Update Automatically: The intrinsic value and NPV calculations refresh in real-time.
  • Test Scenarios: Generate various forecasts and instantly compare results.
  • Make Decisions: Utilize the valuation findings to inform your investment approach.

Why Choose This Calculator for 10x Genomics, Inc. (TXG)?

  • Accurate Data: Real 10x Genomics financials ensure reliable valuation results.
  • Customizable: Adjust key parameters like growth rates, WACC, and tax rates to match your projections.
  • Time-Saving: Pre-built calculations eliminate the need to start from scratch.
  • Professional-Grade Tool: Designed for investors, analysts, and consultants in the genomics field.
  • User-Friendly: Intuitive layout and step-by-step instructions make it easy for all users.

Who Should Use This Product?

  • Investors: Evaluate 10x Genomics’ valuation before making investment decisions.
  • CFOs and Financial Analysts: Optimize valuation processes and assess future projections.
  • Biotech Entrepreneurs: Understand how leading biotech firms like 10x Genomics are valued.
  • Consultants: Provide comprehensive valuation reports to clients in the biotech sector.
  • Students and Educators: Utilize real-world data to learn and teach valuation methodologies.

What the Template Contains

  • Pre-Filled Data: Includes 10x Genomics, Inc.'s historical financials and forecasts.
  • Discounted Cash Flow Model: Editable DCF valuation model with automatic calculations.
  • Weighted Average Cost of Capital (WACC): A dedicated sheet for calculating WACC based on custom inputs.
  • Key Financial Ratios: Analyze 10x Genomics, Inc.'s profitability, efficiency, and leverage.
  • Customizable Inputs: Edit revenue growth, margins, and tax rates with ease.
  • Clear Dashboard: Charts and tables summarizing key valuation results.

No products were found matching.